MarketResearch.biz delivers in-depth insights on the global antithrombin market in its upcoming report titled, “Global Antithrombin Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027”. The global drugs market is estimated to register a CAGR of X.X% in terms of value during forecast period 2018–2027. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global antithrombin market report has been segmented on the basis of application, source, form, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzsed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Thrombin is a unique molecule that functions as a procoagulant as well as an anticoagulant. Antithrombin is a 58 kDa single-chain plasma glycoprotein and a member of the serpin family of serine protease inhibitors. It is a small glycoprotein produced by the liver which inactivates several enzymes of the coagulation system and helps to protect from clotting.
Increasing number of cases of coagulation disorder across the globe is turn expected to create demand for antithrombin, as antithrombin inhibits coagulation by neutralizing the enzymatic activity of thrombin, which in turn is expected to drive growth of the global antithrombin market over the forecast period. Companies investing in research and development of innovative and novel antithrombin is another factor expected to fuel growth of the global antithrombin market over the forecast period. Increasing number of product approvals coupled with emerging therapeutic applications of antithrombin for several medical conditions, is expected to support growth of target market over the forecast period.
On the basis of dosage form, the global antithrombin market is segmented based on lyophilized and liquid. The lyophilized dosage form is expected account for significant revenue share of the market.
North America market dominates the global antithrombin market in terms of revenue contribution as compared to that of markets in other regions. This is attributed to the increasing number of approval for antithrombin in the region. Europe accounts for second-largest revenue share contribution to the global antithrombin market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is projected to register comparatively faster growth in terms of revenue over the next 10 years. Increasing prevalence of blood clot disorders in the country in the region coupled with rising awareness about blood clotting disorders are major factor expected to support growth of the market in the region over the forecast period.
Target audience for the global antithrombin market includes antithrombin manufacturers, government organizations, research associations, and supplier and distributor for antithrombin etc.
Global antithrombin market segmentation, by application:
Global antithrombin market segmentation, by source
- Goat Milk
Global antithrombin market, by dosage form
Global antithrombin market segmentation, by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- Shire Plc.
- rEVO Biologics Inc.
- CSL Limited
- Kedrion S.p.A
- Lee Bisolutions
- Scripps Laboratories Inc.
- GTC Biotherapeutics, Inc
- Green Cross Corp.
- BDI Pharma
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!